Literature DB >> 11309441

Familial risk of pancreatic cancer.

M Schenk1, A G Schwartz, E O'Neal, M Kinnard, J K Greenson, J P Fryzek, G S Ying, D H Garabrant.   

Abstract

BACKGROUND: Pancreatic cancer is the fifth leading cause of cancer-related mortality in the United STATES: Although smoking and age are known risk factors for pancreatic cancer, several case reports and case-control studies have suggested that there is also a familial risk. We evaluated whether a family history of pancreatic cancer increases the risk of pancreatic cancer in first-degree relatives and whether smoking and younger age at cancer diagnosis further increase this risk.
METHODS: We conducted in-person interviews with 247 patients ("case probands") with pancreatic cancer and 420 population-based control probands to collect risk factor data and pancreatic cancer family history for 1816 first-degree relatives of the case probands and 3157 first-degree relatives of the control probands. We analyzed the data by unconditional logistic regression models, with adjustment for correlated data by use of generalized estimating equations. All statistical tests were two-sided.
RESULTS: A positive family history of pancreatic cancer (i.e., being related to a case proband) or ever-smoking cigarettes approximately doubled the risk of pancreatic cancer (relative risk [RR] = 2.49; 95% confidence interval [CI] = 1.32 to 4.69; RR = 2.04; 95% CI = 1.09 to 3.83, respectively). The RR increased to 8.23 (95% CI = 2.18 to 31.07) for relatives who ever smoked and were related to a case proband who was diagnosed before age 60 years.
CONCLUSION: Routine questioning of patients about a family history of pancreatic cancer, the age of onset of this cancer in their relatives, and the patient's smoking status may identify individuals at high risk of pancreatic cancer. Future research exploring the genetic and environmental interactions associated with the risk of pancreatic cancer is critically important.

Entities:  

Mesh:

Year:  2001        PMID: 11309441     DOI: 10.1093/jnci/93.8.640

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  40 in total

1.  Genetic susceptibility to pancreatic cancer.

Authors:  Alison P Klein
Journal:  Mol Carcinog       Date:  2012-01       Impact factor: 4.784

2.  Role of BRCA1 and BRCA2 mutations in pancreatic cancer.

Authors:  Julia B Greer; David C Whitcomb
Journal:  Gut       Date:  2006-09-14       Impact factor: 23.059

3.  Advances in counselling and surveillance of patients at risk for pancreatic cancer.

Authors:  Randall E Brand; Markus M Lerch; Wendy S Rubinstein; John P Neoptolemos; David C Whitcomb; Ralph H Hruban; Teresa A Brentnall; Henry T Lynch; Marcia I Canto
Journal:  Gut       Date:  2007-10       Impact factor: 23.059

Review 4.  Family history is a significant risk factor for pancreatic cancer: results from a systematic review and meta-analysis.

Authors:  Jennifer Permuth-Wey; Kathleen M Egan
Journal:  Fam Cancer       Date:  2008-09-02       Impact factor: 2.375

Review 5.  Inherited pancreatic cancer.

Authors:  Fei Chen; Nicholas J Roberts; Alison P Klein
Journal:  Chin Clin Oncol       Date:  2017-12

6.  Hereditary pancreatitis: endoscopic and surgical management.

Authors:  Eugene P Ceppa; Henry A Pitt; JoAnna L Hunter; Charles M Leys; Nicholas J Zyromski; Frederick J Rescorla; Kumar Sandrasegaran; Evan L Fogel; Lee W McHenry; James L Watkins; Stuart Sherman; Glen A Lehman
Journal:  J Gastrointest Surg       Date:  2013-02-23       Impact factor: 3.452

7.  Detection of pancreatic cancer using serum protein profiling.

Authors:  Berit Velstra; Bert A Bonsing; Bart J Mertens; Yuri E M van der Burgt; Anouck Huijbers; Hans Vasen; Wilma E Mesker; André M Deelder; Rob A E M Tollenaar
Journal:  HPB (Oxford)       Date:  2012-11-30       Impact factor: 3.647

8.  Risk factors for pancreatic cancer: case-control study.

Authors:  Manal M Hassan; Melissa L Bondy; Robert A Wolff; James L Abbruzzese; Jean-Nicolas Vauthey; Peter W Pisters; Douglas B Evans; Rabia Khan; Ta-Hsu Chou; Renato Lenzi; Li Jiao; Donghui Li
Journal:  Am J Gastroenterol       Date:  2007-08-31       Impact factor: 10.864

Review 9.  Identifying people at a high risk of developing pancreatic cancer.

Authors:  Alison P Klein
Journal:  Nat Rev Cancer       Date:  2012-12-06       Impact factor: 60.716

10.  ABO blood group and the risk of pancreatic cancer.

Authors:  Brian M Wolpin; Andrew T Chan; Patricia Hartge; Stephen J Chanock; Peter Kraft; David J Hunter; Edward L Giovannucci; Charles S Fuchs
Journal:  J Natl Cancer Inst       Date:  2009-03-10       Impact factor: 13.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.